BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17220666)

  • 1. [Chemotherapy in advanced gastric cancer--to ensure timely and appropriate switch to subsequent treatment options].
    Yamaguchi K; Shimamura T; Ishikubo T; Fujino K; Tada M
    Gan To Kagaku Ryoho; 2007 Jan; 34(1):29-34. PubMed ID: 17220666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in chemotherapy for advanced gastric cancer].
    Xu RH; Teng KY
    Ai Zheng; 2009 Oct; 28(10):1108-13. PubMed ID: 19799823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [CPT-11 combined chemotherapy for metastatic gastric cancer].
    Narahara H; Sugimoto N; Iishi H; Tatsuta M
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1973-7. PubMed ID: 15570923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Latest progress on chemotherapy for advanced gastric cancer].
    Tahara M; Ohtsu A
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2048-58. PubMed ID: 11103236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical development of chemotherapy for advanced gastric cancer].
    Sato A; Matsukawa M
    Nihon Shokakibyo Gakkai Zasshi; 2007 Feb; 104(2):186-93. PubMed ID: 17283412
    [No Abstract]   [Full Text] [Related]  

  • 6. [S-1 for gastric cancer-S-1 monotherapy and its progress].
    Shitara K; Sakata Y; Kudou T; Munakata M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():43-51. PubMed ID: 16897971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemotherapy for gastric cancer].
    Baba H; Kakeji Y; Oki E; Tokunaga E; Ushiro S; Watanabe M; Maehara Y
    Gan To Kagaku Ryoho; 2003 Nov; 30(12):1881-8. PubMed ID: 14650954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances in chemotherapy for digestive cancers with special references to gastric and colonic cancers].
    Sawabu N
    Nihon Shokakibyo Gakkai Zasshi; 2003 Jun; 100(6):645-52. PubMed ID: 12833857
    [No Abstract]   [Full Text] [Related]  

  • 9. [The choice of treatment in advanced gastric cancer].
    Pozzo C; Mansueto G
    Tumori; 2007; 93(6):suppl 11-21. PubMed ID: 18338512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical development of S-1 (TS-1) for advanced gastric cancer].
    Wasaburo K; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Mihara S; Nakatani K; Nishimura K; Shimoda T; Azuma M; Katada C; Hanaoka N; Naruke A; Ryu T; Ishido K; Saigenji K
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():57-63. PubMed ID: 16897973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Controversial issues in chemotherapy for inoperable gastric cancer].
    Koizumi W; Tanabe S; Higuchi K; Sasaki T; Nakayama N; Nagaba S; Kitamura T; Azuma M; Saigenji K
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1249-55. PubMed ID: 14518402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current combination chemotherapy containing paclitaxel for advanced, recurrent gastric cancer].
    Emi Y; Kakeji Y; Baba H; Ishida T; Maehara Y
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1978-81. PubMed ID: 15570924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase II study of docetaxel and oxaliplatin combination in recurrent gastric cancer patients after fluoropyrimidine and/or cisplatin adjuvant treatment: a Korean Cancer Study Group Protocol ST06-02.
    Choi YH; Oh SC; Kim JS; Nam SH; Kim BS; Cho SH; Chung IJ; Song EK; Yim CY; Baek JH; Jeung HC; Hong YS; Yang SH; Kang HJ
    Cancer Chemother Pharmacol; 2012 Nov; 70(5):665-72. PubMed ID: 22926638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of chemotherapy using new anti-cancer drugs since S-1 for advanced or recurrent gastric cancer in our institute].
    Sato T; Kikuchi Y; Saito T; Hirano S; Kouzuma T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1819-25. PubMed ID: 18030016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy of advanced gastric cancer.
    Rivera F; Vega-Villegas ME; López-Brea MF
    Cancer Treat Rev; 2007 Jun; 33(4):315-24. PubMed ID: 17376598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Second-line chemotherapy in gastric cancer following S-1 with CPT-11 chemotherapy performed as clinical trial].
    Inokuchi M; Yamashita T; Yamada H; Kojima K; Sekita Y; Kawano T; Sugihara K
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):875-9. PubMed ID: 17565249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic strategy for type 4 gastric cancer from the clinical oncologist standpoint].
    Sasaki T; Koizumi W; Higuchi K; Ishido K; Ae T; Nakatani K; Katada C; Tanabe S; Saigenji K
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):988-92. PubMed ID: 17637532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S-1 with leucovorin and oxaliplatin for advanced gastric cancer.
    Ter Veer E; van Oijen MGH; van Laarhoven HWM
    Lancet Oncol; 2016 Feb; 17(2):e41. PubMed ID: 26868348
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current evidence of irinotecan combination chemotherapy with TS-1 in patients with advanced colorectal cancer].
    Goto A
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):896-900. PubMed ID: 16835475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Controversy of treatment for advanced colorectal cancer--intermedisine].
    Sato A; Shimada K; Taguchi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1260-9. PubMed ID: 14518404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.